Kawasaki disease triggered by parvovirus infection: an atypical case report of two siblings.


Journal

Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382

Informations de publication

Date de publication:
24 Apr 2019
Historique:
received: 06 06 2018
accepted: 24 02 2019
entrez: 25 4 2019
pubmed: 25 4 2019
medline: 26 11 2019
Statut: epublish

Résumé

There are reports of the familial occurrence of Kawasaki disease but only a few reports described Kawasaki disease in siblings. However, the familial cases were not simultaneous. In these patients the idea of infective agents as trigger must be considered. We describe two siblings with atypical presentations of Kawasaki disease; the sister was first diagnosed as having parvovirus infection with anemia and the brother was diagnosed as having myocarditis. The first patient was a 9-month-old Caucasian girl with fever, conjunctivitis, rash, and pharyngitis, and later she had cervical adenopathy, diarrhea and vomiting, leukocytosis, and anemia, which were explained by positive immunoglobulin M against parvovirus. However, coronary artery lesions with aneurysms were documented at day 26 after fever onset. An infusion of intravenous immunoglobulin and high doses of steroids were not efficacious to resolve the coronary lesions. She was treated with anakinra, despite a laboratory test not showing inflammation, with prompt and progressive improvement of coronary lesions. Her 7-year-old Caucasian brother presented vomiting and fever at the same time as she was unwell, which spontaneously resolved after 4 days. Four days later, he again presented with fever with abdominal pain, associated with tachypnea, stasis at the pulmonary bases, tachycardia, gallop rhythm, hypotension, secondary anuria, and hepatomegaly. An echocardiogram revealed a severe hypokinesia, with a severe reduction of the ejection fraction (20%). He had an increase of immunoglobulin M anti-parvovirus, tested for the index case of his sister, confirming the suspicion of viral myocarditis. He received dopamine, dobutamine, furosemide plus steroids, with a progressive increase of the ejection fraction to 50%. However, evaluating his sister's history, the brother showed a myocardial dysfunction secondary to Kawasaki shock syndrome. We report on familial Kawasaki disease in two siblings which had the same infectious trigger (a documented parvovirus infection). The brother was diagnosed as having post-viral myocarditis. However, in view of the two different and simultaneous evolutions, the girl showed Kawasaki disease with late coronary artery lesions and aneurysms, whereas the brother showed Kawasaki shock syndrome with myocardial dysfunction. We stress the effectiveness of anakinra in non-responder Kawasaki disease and the efficacy on coronary aneurysms.

Sections du résumé

BACKGROUND BACKGROUND
There are reports of the familial occurrence of Kawasaki disease but only a few reports described Kawasaki disease in siblings. However, the familial cases were not simultaneous. In these patients the idea of infective agents as trigger must be considered.
CASE PRESENTATION METHODS
We describe two siblings with atypical presentations of Kawasaki disease; the sister was first diagnosed as having parvovirus infection with anemia and the brother was diagnosed as having myocarditis. The first patient was a 9-month-old Caucasian girl with fever, conjunctivitis, rash, and pharyngitis, and later she had cervical adenopathy, diarrhea and vomiting, leukocytosis, and anemia, which were explained by positive immunoglobulin M against parvovirus. However, coronary artery lesions with aneurysms were documented at day 26 after fever onset. An infusion of intravenous immunoglobulin and high doses of steroids were not efficacious to resolve the coronary lesions. She was treated with anakinra, despite a laboratory test not showing inflammation, with prompt and progressive improvement of coronary lesions. Her 7-year-old Caucasian brother presented vomiting and fever at the same time as she was unwell, which spontaneously resolved after 4 days. Four days later, he again presented with fever with abdominal pain, associated with tachypnea, stasis at the pulmonary bases, tachycardia, gallop rhythm, hypotension, secondary anuria, and hepatomegaly. An echocardiogram revealed a severe hypokinesia, with a severe reduction of the ejection fraction (20%). He had an increase of immunoglobulin M anti-parvovirus, tested for the index case of his sister, confirming the suspicion of viral myocarditis. He received dopamine, dobutamine, furosemide plus steroids, with a progressive increase of the ejection fraction to 50%. However, evaluating his sister's history, the brother showed a myocardial dysfunction secondary to Kawasaki shock syndrome.
CONCLUSIONS CONCLUSIONS
We report on familial Kawasaki disease in two siblings which had the same infectious trigger (a documented parvovirus infection). The brother was diagnosed as having post-viral myocarditis. However, in view of the two different and simultaneous evolutions, the girl showed Kawasaki disease with late coronary artery lesions and aneurysms, whereas the brother showed Kawasaki shock syndrome with myocardial dysfunction. We stress the effectiveness of anakinra in non-responder Kawasaki disease and the efficacy on coronary aneurysms.

Identifiants

pubmed: 31014402
doi: 10.1186/s13256-019-2028-5
pii: 10.1186/s13256-019-2028-5
pmc: PMC6480815
doi:

Substances chimiques

Cardiotonic Agents 0
Immunologic Factors 0
Immunosuppressive Agents 0
Interleukin 1 Receptor Antagonist Protein 0
Dobutamine 3S12J47372
Dopamine VTD58H1Z2X

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104

Références

Arch Pediatr Adolesc Med. 2005 Sep;159(9):876-81
pubmed: 16143748
J Vet Med B Infect Dis Vet Public Health. 2005 Sep-Oct;52(7-8):344-7
pubmed: 16316398
Pediatr Allergy Immunol. 2010 Nov;21(7):1091-2
pubmed: 20977502
Eur J Gastroenterol Hepatol. 2011 Mar;23(3):289
pubmed: 21304320
New Microbiol. 2011 Oct;34(4):421-4
pubmed: 22143818
J Am Soc Echocardiogr. 2016 Feb;29(2):150-7
pubmed: 26386984
Contemp Clin Trials. 2016 May;48:70-5
pubmed: 27080929
Curr Opin Rheumatol. 2016 Jul;28(4):383-9
pubmed: 27166925
Ital J Pediatr. 2016 Nov 2;42(1):92
pubmed: 27806720
BMC Pediatr. 2017 Apr 8;17(1):102
pubmed: 28390409
Front Pharmacol. 2017 Mar 28;8:163
pubmed: 28400731
Cardiol Young. 2018 May;28(5):739-742
pubmed: 29455693
Ital J Pediatr. 2018 Aug 30;44(1):103
pubmed: 30157893
Ital J Pediatr. 2018 Aug 30;44(1):102
pubmed: 30157897

Auteurs

M C Maggio (MC)

University Department promise "G. D'Alessandro", University of Palermo, Palermo, Italy. mariacristina.maggio@unipa.it.

R Cimaz (R)

NEUROFARBA Department, University of Florence, Florence, Italy.
Azienda Ospedaliero Universitaria (AOU) Meyer, Florence, Italy.

A Alaimo (A)

Paediatric Cardiology Unit, Children Hospital "G. Di Cristina", ARNAS, Palermo, Italy.

C Comparato (C)

Paediatric Cardiology Unit, Children Hospital "G. Di Cristina", ARNAS, Palermo, Italy.

D Di Lisi (D)

Paediatric Cardiology Unit, Children Hospital "G. Di Cristina", ARNAS, Palermo, Italy.

G Corsello (G)

University Department promise "G. D'Alessandro", University of Palermo, Palermo, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH